BIOLIFE PLASMA SERVICE
- Buzz: Baxalta hunts for a buyout after rejecting Shire offer Fierce Biotech News
- Deals Rumor Mill: Baxalta, Worldpay, Qihoo 360 Law 360 Technology
- Baxter and Water Street Announce FDA Approval of CEFAZOLIN 2 Gram Premix Business Wire Health News
- Baxalta Completes ONCASPAR Portfolio Acquisition, Aims to Broaden Patient Access to Leading Treatmen Business Wire Health News
- Baxter Initiates Voluntary Recall Of Two Lots Of IV Solutions Due To The Potential Presence Of Parti FDA Recalls
- Baxter Shares Bid Up Ahead Of Spinoff Investor's Business Daily Investing News
- Baxter Announces Debt Tender Offers Business Wire Health News
- Baxter Initiates Voluntary Recall of Select Product Codes of Peripheral Vascular Patch FDA Recalls
- Baxter International Launches a New Biotech in South San Francisco Bio Space - All News
- Novo Nordisk rejects Baxter patent claim over Novoeight Reuters - Sectors - Healthcare
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on BIOLIFE PLASMA SERVICE
- Rate BIOLIFE PLASMA SERVICE on their payment behavior
- Ask your network about BIOLIFE PLASMA SERVICE with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.